Publication

The Effect of Topiramate Plasma Concentration on Linguistic Behavior, Verbal Recall and Working Memory

Downloadable Content

Persistent URL
Last modified
  • 05/15/2025
Type of Material
Authors
    S. E. Marino, University of MinnesotaS. V. S. Pakhomov, University of MinnesotaS. Han, University of FloridaK. L. Anderson, University of FloridaM. Ding, University of FloridaL. E. Eberly, University of MinnesotaDavid W Loring, Emory UniversityC. Hawkins-Taylor, University of MinnesotaJ. O. Rarick, University of MinnesotaI. E. Leppik, University of MinnesotaJ. E. Cibula, University of FloridaA. K. Birnbaum, University of Minnesota
Language
  • English
Date
  • 2012-05-30
Publisher
  • Elsevier
Publication Version
Copyright Statement
  • © 2012 Elsevier Inc. All rights reserved.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1525-5050
Grant/Funding Information
  • This work was supported by the National Institutes of Health/National Institute for Neurological Diseases and Stroke [K 01 NS050309 to S.E.M.]; National Institute for Aging [R01 AG026490 to A.K.B.] and University of Minnesota/Academic Health Center Faculty Research Development Award [to S.E.M., S.V.S.P., A.K.B.]
Abstract
  • This is the first study of the effect of topiramate on linguistic behavior and verbal recall using a computational linguistics system for automated language and speech analysis to detect and quantify drug-induced changes in speech recorded during discourse-level tasks. Healthy volunteers were administered a single, 100-mg oral dose of topiramate in two double-blind, randomized, placebo-controlled, crossover studies. Subjects' topiramate plasma levels ranged from 0.23 to 2.81 μg/mL. We found a significant association between topiramate levels and impairment on measures of verbal fluency elicited during a picture description task, correct number of words recalled on a paragraph recall test, and reaction time recorded during a working memory task. Using the tools of clinical pharmacology and computational linguistics, we elucidated the relationship between the determinants of a drug's disposition as reflected in plasma concentrations and their impact on cognitive functioning as reflected in spoken language discourse.
Author Notes
  • S. E. Marino, PhD, Center for Clinical and Cognitive Neuropharmacology, University of Minnesota, 717 Delaware Street SE, Minneapolis MN 55414. Telephone: 612-624-2964 Fax: 612-626-0148; marin007@umn.edu.
Research Categories
  • Health Sciences, Medicine and Surgery
  • Biology, Neuroscience

Tools

Relations

In Collection:

Items